Elevated Serum Growth Differentiation Factor 15 Levels Predict Poor Prognosis in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation
Circulation Reports · 10.11.2026 · 8 (11) · 1891-1902
DOI: 10.1253/circrep.cr-26-0242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Reports, erschienen am 10.11.2026. Verfasst von Shunsuke Edamura und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine Yamagata Japan. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Despite transcatheter aortic valve implantation (TAVI) reducing cardiovascular events in elderly patients with aortic stenosis (AS), the mortality rate is still high. Growth differentiation factor (GDF) 15 is reportedly a useful prognostic marker for clinical outcomes in the field of cardiovascular diseases, but it is still unclear if elevated serum GDF15 levels predict poor prognosis in patients with severe AS who undergo TAVI. Methods and Results: We measured the pre- and postoperative serum concentrations of GDF15 in 148 patients. The primary and secondary endpoints were all-cause death and a composite event including cardiovascular death, heart failure rehospitalization, stroke, and adverse bleeding event, respectively. There were 30 all-cause deaths and 21 composite events during a median follow-up period of 1,023 days. Both pre- and postoperative serum GDF15 levels were significantly increased with advancing Society of Thoracic Surgeons Predicted Risk of Mortality score. Multivariate Cox proportional hazards analysis revealed that preoperative serum GDF15 level was independently associated with the primary and secondary endpoints, and the postoperative serum GDF15 level was independently associated with the primary endpoint after adjustment for confounding risk factors. Receiver operating characteristic curve analysis for the primary endpoint showed a comparable area under the curve for the pre- and postoperative serum GDF15 levels.
Conclusions
Both the pre- and postoperative GDF15 concentration could be a feasible marker for clinical outcomes in Japanese patients undergoing TAVI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine Yamagata Japan.
Zitieren
APA
Edamura, S., Tamura, H., Otaki, Y., Iizuka, A., Kobayashi, T., Sugai, T., Wanezaki, M., Nishiyama, S., Hashimoto, N., Kinoshita, D., Kato, S., Arimoto, T., Watanabe, T., & Watanabe, M. (2026). Elevated Serum Growth Differentiation Factor 15 Levels Predict Poor Prognosis in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. Circulation Reports, 8(11), 1891-1902. https://doi.org/10.1253/circrep.cr-26-0242
Vancouver
Edamura S, Tamura H, Otaki Y, Iizuka A, Kobayashi T, Sugai T, et al. Elevated Serum Growth Differentiation Factor 15 Levels Predict Poor Prognosis in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. Circulation Reports. 2026;8(11):1891-1902. doi:10.1253/circrep.cr-26-0242
BibTeX
@article{Edamura2026,
author = {Edamura, Shunsuke and Tamura, Harutoshi and Otaki, Yoichiro and Iizuka, Atsushi and Kobayashi, Tomoki and Sugai, Takayuki and Wanezaki, Masahiro and Nishiyama, Satoshi and Hashimoto, Naoaki and Kinoshita, Daisuke and Kato, Shigehiko and Arimoto, Takanori and Watanabe, Tetsu and Watanabe, Masafumi},
title = {Elevated Serum Growth Differentiation Factor 15 Levels Predict Poor Prognosis in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation},
journal = {Circulation Reports},
year = {2026},
volume = {8},
number = {11},
pages = {1891--1902},
doi = {10.1253/circrep.cr-26-0242}
}
EUVIMED